I Want To...
Find a Doctor
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
William H Sharfman, M.D.
Director, Cutaneous Oncology
Associate Professor of Oncology
Specializes in: Adults (18+ years)
Expertise: Cutaneous Oncology, Dermatology, Gastrointestinal Cancers, Immunotherapy, Lung Cancer, Melanoma, Merkel Cell Carcinoma, Neuroendocrine Tumors
Research Interests: Novel therapies for high risk and advanced melanoma patients; GI Cancers; Lung Cancer
Request an Appointment
Johns Hopkins Medicine - Green Spring Station
Appointment Phone: 410-616-7660
Green Spring Station
10753 Falls Road
Baltimore, MD 21093 map
Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology, gastrointestinal cancers and immunotherapy. He helped create the well-established Melanoma Program at Johns Hopkins in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program.
He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic.
Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients; GI cancers; and lung cancer.
- Director, Cutaneous Oncology
- Clinical Co-Director for Oncology, Johns Hopkins Melanoma Program
- Associate Professor of Oncology
- Associate Professor of Dermatology
Centers & Institutes
- MD, University of Toledo College of Medicine and Life Sciences (1982)
- Cleveland Clinic / Internal Medicine (1985)
- Cleveland Clinic / Hematology and Oncology (1989)
- American Board of Internal Medicine / Hematology (1992, 2012)
- American Board of Internal Medicine / Internal Medicine (1986)
- American Board of Internal Medicine / Medical Oncology (1989)
Research & Publications
Dr. Sharfman’s research focuses on melanoma, including novel therapies for advanced melanoma patients.
- Lange, J.R.; Fecher, L.; Sharfman, W.H.; Alani, R.M.; Mikkilineni, R.; Topalian, S.L.; Balch, C.M. Melanoma. In: Abeloff MD, A.J., Niederhuber JE, Kastan MB, McKenna WG editor. 4th ed, Abeloffs Clinical Oncology. Philadelphia: Elsevier Inc.; 2008. p. 1229-1252.
- Brahmer, J.R.; Drake, C.G.; Wollner, I.; Powderly, J.D.; Picus, J.; Sharfman, W.H.; Stankevich, E.; Pons, A.; Salay, T.M.; McMiller, T.L.; Gilson, M.M.; Wang, C.; Selby, M.; Taube, J.M.; Anders, R.; Chen, L.; Korman, A.J.; Pardoll, D.M.; Lowy, I.; Topalian, S.L. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010 Jul 1;28(19):3167-3175.